Effectiveness of an ADE-related Hospitalization Risk Prediction Tool for Patients (ADE-RED)
- Conditions
- Adverse Drug Event
- First Posted Date
- 2019-11-29
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Methodist Health System
- Target Recruit Count
- 471
- Registration Number
- NCT04181775
- Locations
- ๐บ๐ธ
Methodist Dallas Medical Center, Dallas, Texas, United States
Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis
- Conditions
- CirrhosisSpontaneous Bacterial Peritonitis
- First Posted Date
- 2019-11-06
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- Methodist Health System
- Target Recruit Count
- 841
- Registration Number
- NCT04153604
- Locations
- ๐บ๐ธ
Methodist Dallas Medical Center, Dallas, Texas, United States
Efficacy and Safety of Direct Oral Anticoagulants for the Treatment of Mural Thrombus
- Conditions
- Acute Myocardial Infarction
- First Posted Date
- 2019-11-06
- Last Posted Date
- 2021-12-13
- Lead Sponsor
- Methodist Health System
- Target Recruit Count
- 75
- Registration Number
- NCT04153591
- Locations
- ๐บ๐ธ
Methodist Dallas Medical Center, Dallas, Texas, United States
Time to Lose the Weight? Comparison of Weight-based and Non-weight-based Vasopressors for Septic Shock
- Conditions
- Septic ShockWeight, Body
- First Posted Date
- 2019-11-06
- Last Posted Date
- 2021-11-11
- Lead Sponsor
- Methodist Health System
- Target Recruit Count
- 945
- Registration Number
- NCT04153578
- Locations
- ๐บ๐ธ
Methodist Dallas Medical Center, Dallas, Texas, United States
Fecal Microbiota Transplant
- Conditions
- Clostridium Difficile Infection
- Interventions
- Drug: Fecal Microbiota Transplant
- First Posted Date
- 2019-09-16
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Methodist Health System
- Target Recruit Count
- 24
- Registration Number
- NCT04090346
- Locations
- ๐บ๐ธ
Methodist Mansfield Medical Center, Dallas, Texas, United States
TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer
- Conditions
- Liver, Cancer of, Non-Resectable
- First Posted Date
- 2019-09-16
- Last Posted Date
- 2021-11-11
- Lead Sponsor
- Methodist Health System
- Target Recruit Count
- 187
- Registration Number
- NCT04090645
- Locations
- ๐บ๐ธ
The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, United States
Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
- Conditions
- Neuroendocrine Tumors
- First Posted Date
- 2019-09-16
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- Methodist Health System
- Target Recruit Count
- 50
- Registration Number
- NCT04090034
- Locations
- ๐บ๐ธ
Clinical Research Institute at Methodist Health System, Dallas, Texas, United States
๐บ๐ธMethodist Dallas Medical Center, Dallas, Texas, United States
Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy
- Conditions
- Chronic HepaticLiver Diseases
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2021-06-28
- Lead Sponsor
- Methodist Health System
- Target Recruit Count
- 24
- Registration Number
- NCT04055870
- Locations
- ๐บ๐ธ
Methodist Dallas Medical Center, Dallas, Texas, United States
Comparison of Solid Organ Transplant
- Conditions
- Gram-negative BacteremiaMultidrug-Resistant OrganismGram-Negative Bacterial InfectionsHospital-acquired PneumoniaHealthcare-associated Pneumonia
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2020-01-02
- Lead Sponsor
- Methodist Health System
- Target Recruit Count
- 150
- Registration Number
- NCT04055922
- Locations
- ๐บ๐ธ
Methodist Dallas Medical Center, Dallas, Texas, United States
Outpatient Office Based Endovascular Procedures
- Conditions
- Chronic Venous InsufficiencyPeripheral Arterial DiseaseDialysis Access MalfunctionArterio-venous FistulaVertebral Artery InsufficiencyThoracic Outlet SyndromeVaricose Veins
- First Posted Date
- 2019-08-13
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- Methodist Health System
- Target Recruit Count
- 300
- Registration Number
- NCT04054440
- Locations
- ๐บ๐ธ
Methodist Dallas Medical Center, Dallas, Texas, United States